Biological Profile and Clinical Features as Determinants for Prolonged Hospitalization in Adult Patients with Measles: A Monocentric Study in Western Romania.

infectious disease measles public health

Journal

Pathogens (Basel, Switzerland)
ISSN: 2076-0817
Titre abrégé: Pathogens
Pays: Switzerland
ID NLM: 101596317

Informations de publication

Date de publication:
07 Sep 2022
Historique:
received: 10 08 2022
revised: 02 09 2022
accepted: 06 09 2022
entrez: 23 9 2022
pubmed: 24 9 2022
medline: 24 9 2022
Statut: epublish

Résumé

Measles is a highly infectious and sometimes deadly illness that is preventable with vaccination. The present research aims to analyze the most recent measles epidemic from Romania that occurred in a population with a falling desire to receive immunizations, by detailing the clinical picture and biological profile of hospitalized patients. A secondary goal of the present research is to identify characteristics that increase the likelihood of a longer hospitalization and the development of measles-related pneumonia. A retrospective cohort study was conducted to follow the course and effects of measles virus infection in adult hospitalized patients who were divided into two groups based on whether they had been in the hospital for more than 6 days or fewer than 6 days. A total of 114 adult patients with measles were eligible to participate in the trial if they had a positive measles-specific IgM antibody test resulting from the study. The average age in the short hospital stay group was 28.1 years, while the average age in the long hospital stay group was 31.9 years. There was a statistically significant difference in the number of Roma persons in the research groups, with 17.4 percent of them having a lengthy hospital stay compared to 5.9 percent in the group with a short hospital stay, according to the findings. It was observed that many patients had a long hospitalization associated with chronic lung disease (OR = 1.07), liver damage (OR = 1.66), Roma ethnicity (OR = 1.79), a long duration elapsed from the last MMR dose (OR = 2.02), elevated c-reactive protein (OR = 2.17), the presence of bilateral pulmonary condensations on X-ray (OR = 3.13), and elevated procalcitonin (OR = 3.49). The same significant independent risk factors were also associated with the development of pneumonia. It is of imperative need to address these risk factors in a patient with measles, moreover in association with an unknown status of vaccination. Vaccination awareness against measles must be pushed in Romania to determine a higher than 95% coverage. Significant efforts are still needed to ensure improved protection against measles epidemics within a specific region or population and, more importantly, in patients with significant risk factors for complications, as described in this study.

Identifiants

pubmed: 36145449
pii: pathogens11091018
doi: 10.3390/pathogens11091018
pmc: PMC9505879
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

J Pers Med. 2021 Nov 13;11(11):
pubmed: 34834548
Vaccines (Basel). 2019 Jan 16;7(1):
pubmed: 30654577
Int J Infect Dis. 2013 Dec;17(12):e1243-4
pubmed: 23938044
Viruses. 2019 Nov 02;11(11):
pubmed: 31684034
J Infect Dis. 2006 Sep 15;194(6):781-9
pubmed: 16941344
J Indian Med Assoc. 2011 Sep;109(9):666-7
pubmed: 22480102
Int J Mol Sci. 2020 Aug 04;21(15):
pubmed: 32759702
Clin Microbiol Infect. 2017 Aug;23(8):511-515
pubmed: 28412379
Microorganisms. 2020 Feb 18;8(2):
pubmed: 32085446
BMC Infect Dis. 2021 Dec 9;21(1):1237
pubmed: 34886804
Front Public Health. 2019 Apr 25;7:98
pubmed: 31073518
Antibiotics (Basel). 2022 Mar 24;11(4):
pubmed: 35453189
J Infect Dis. 2021 Sep 30;224(12 Suppl 2):S452-S467
pubmed: 34590130
Antimicrob Agents Chemother. 2001 Mar;45(3):943-5
pubmed: 11181386
Clin Infect Dis. 2021 Nov 16;73(10):1920-1923
pubmed: 33580243
Int J Mol Epidemiol Genet. 2021 Jun 15;12(3):35-39
pubmed: 34336136
Medicine (Baltimore). 2017 Dec;96(50):e9154
pubmed: 29390321
MMWR Morb Mortal Wkly Rep. 2020 Nov 13;69(45):1700-1705
pubmed: 33180759
Viruses. 2016 Jul 28;8(8):
pubmed: 27483301
Virulence. 2020 Dec;11(1):686-694
pubmed: 32507005
Obstet Gynecol. 2015 Jul;126(1):163-70
pubmed: 25899422
BMC Infect Dis. 2020 Mar 29;20(1):251
pubmed: 32223757
MMWR Morb Mortal Wkly Rep. 1983 Jan 7;31(52):707-11
pubmed: 6402654
Vaccines (Basel). 2020 May 13;8(2):
pubmed: 32414021
Vaccines (Basel). 2022 Feb 10;10(2):
pubmed: 35214732
Hum Vaccin Immunother. 2021 Jul 3;17(7):2078-2084
pubmed: 33502929
Lancet. 2022 Feb 12;399(10325):678-690
pubmed: 35093206
Viruses. 2017 Jan 19;9(1):
pubmed: 28106841
Exp Ther Med. 2021 Aug;22(2):816
pubmed: 34131439
Viruses. 2021 Dec 10;13(12):
pubmed: 34960748
Viruses. 2022 Jan 12;14(1):
pubmed: 35062341
Lancet Infect Dis. 2017 Dec;17(12):e420-e428
pubmed: 28757186
Zdr Varst. 2020 Oct 18;59(4):219-226
pubmed: 33133278
J Perinat Med. 2005;33(1):67-8
pubmed: 15841617
Hum Vaccin Immunother. 2019;15(9):2060-2065
pubmed: 31116633

Auteurs

Mirela Turaiche (M)

Methodological and Infectious Diseases Research Center, Department of Infectious Diseases, "Victor Babes" University of Medicine and Pharmacy, 300041 Timisoara, Romania.

Bogdan Feciche (B)

Department of Urology, Satu-Mare County Emergency Hospital, Strada Ravensburg 2, 440192 Satu-Mare, Romania.

Adrian Gluhovschi (A)

Methodological and Infectious Diseases Research Center, Department of Infectious Diseases, "Victor Babes" University of Medicine and Pharmacy, 300041 Timisoara, Romania.
Department of Obstetrics and Gynecology, "Victor Babes" University of Medicine and Pharmacy Timisoara, Eftimie Murgu Square 2, 300041 Timisoara, Romania.

Felix Bratosin (F)

Methodological and Infectious Diseases Research Center, Department of Infectious Diseases, "Victor Babes" University of Medicine and Pharmacy, 300041 Timisoara, Romania.

Iulia Bogdan (I)

Methodological and Infectious Diseases Research Center, Department of Infectious Diseases, "Victor Babes" University of Medicine and Pharmacy, 300041 Timisoara, Romania.

Adrian Vasile Bota (AV)

Methodological and Infectious Diseases Research Center, Department of Infectious Diseases, "Victor Babes" University of Medicine and Pharmacy, 300041 Timisoara, Romania.

Mirela Loredana Grigoras (ML)

Methodological and Infectious Diseases Research Center, Department of Infectious Diseases, "Victor Babes" University of Medicine and Pharmacy, 300041 Timisoara, Romania.
Department of Anatomy and Embryology, "Victor Babes" University of Medicine and Pharmacy Timisoara, Eftimie Murgu Square 2, 300041 Timisoara, Romania.

Camelia Vidita Gurban (CV)

Methodological and Infectious Diseases Research Center, Department of Infectious Diseases, "Victor Babes" University of Medicine and Pharmacy, 300041 Timisoara, Romania.
Department of Biochemistry, "Victor Babes" University of Medicine and Pharmacy, Eftimie Murgu Square 2, 300041 Timisoara, Romania.

Bianca Cerbu (B)

Methodological and Infectious Diseases Research Center, Department of Infectious Diseases, "Victor Babes" University of Medicine and Pharmacy, 300041 Timisoara, Romania.

Ana-Olivia Toma (AO)

Department of Microbiology, "Victor Babes" University of Medicine and Pharmacy, Eftimie Murgu Square 2, 300041 Timisoara, Romania.

Srivathsava Gurumurthy (S)

Mysore Medical College and Research Institute, Rajiv Gandhi University of Health Sciences, Irwin Road, Mysuru 570001, India.

Prima Hapsari Wulandari (PH)

Massachusetts General Hospital, Harvard Medical School, 55 Fruit St., Boston, MA 02114, USA.

Iosif Marincu (I)

Methodological and Infectious Diseases Research Center, Department of Infectious Diseases, "Victor Babes" University of Medicine and Pharmacy, 300041 Timisoara, Romania.

Classifications MeSH